Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sentinel Lymph Node Mapping in Early Stage Rectal Cancer
NCT02112240Withdrawn
- Sponsor
- University of Virginia
- Start
- May 2013
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of technetium tc 99m sulfur colloid in rectal cancer, sponsored by University of Virginia. Primary endpoint: Sensitivity of identifying the sentinel lymph node at 7 days. Planned start May 2013; status: withdrawn.
02
Drugs
technetium tc 99m sulfur colloid
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT02112240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02112240.